United States· US:0085-2224_56740f7d-3b29-4786-b5c7-eea6c0f14400
NOXAFIL
A posaconazole product containing posaconazole, registered in United States by Merck Sharp & Dohme LLC. The same ATC class is registered in 18 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Posaconazole is registered in 18 of 19 countries.
Countries holding a registration under ATC J02AC04 (posaconazole), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Posaconazole · ATC J02AC04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of posaconazole costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $6.09 in United States to $82.67 in Italy — a ×14 gap.
- United States: $6.09 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Posaconazole · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- IT Italy$82.67
- CH Switzerland$74.94
- US United States$6.09 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- POSACONAZOLE
- Manufacturer
- Merck Sharp & Dohme LLC
- Country
- United States (US)
- ATC code
- J02AC04
- ATC class
- Posaconazole
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1100852224028 PACKET in 1 CARTON (0085-2224-02) / 1 POWDER, FOR SUSPENSION in 1 PACKET (0085-2224-01)
- ndc110085-2224-02
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
415 interactions on record for posaconazole.
Graded by severity as the source publishes them — 143 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Posaconazole · interactions on record
415 records
- 143 severe
- 219 moderate
- 7 minor
- 27 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NaloxegolA06AH03severe
19 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Posaconazole in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumNoxafil 300 mgMerck Sharp & Dohme
- FinlandNoxafilMerck Sharp & Dohme B.V.
- IrelandNoxafil 300 mg gastro-resistant powder for oral suspensionMerck Sharp & Dohme BV,
- IcelandNoxafilMerck Sharp & Dohme B.V.*
- NetherlandsNoxafil 300 mg maagsapresistente poeder en oplosmiddel voor suspensie voor oraal gebruikMerck Sharp & Dohme B.V.
- PolandNoxafilMerck Sharp & Dohme B.V.
- SwedenNoxafil 300 mg Enteropulver och vätska till oral suspensionMerck Sharp & Dohme BV
- CzechiaGUDIVINEgis Pharmaceuticals PLC, Budapešť
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Posaconazol Altan, Posaconazol Ratiopharm
- Belgium · Posaconazol Ab, Posaconazol Sandoz
- Czechia · Gudivin, Posaconazole Accord
- Germany · Ossmiq, Posaconazol
- Denmark · Posaconazol Stada, Posaconazol Teva B.V.
- Estonia · Ossmiq, Posaconazol
- Spain · Posaconazol, Posaconazol Abdi
- Finland · Posaconazol Vivanta, Posaconazole
- France · Posaconazole Accord, Posaconazole Altan
- United Kingdom (Northern Ireland) · Posaconazol Msn Laboratories, Posaconazole
- Greece · Posaconazole Genepharm, Posaconazole Stada
- Croatia · Posakonazol Abdi, Posakonazol Msn
- Hungary · Gudivin, Posaconazol Accord
- Ireland · Posaconazole, Posaconazole Teva
- Iceland · Noxafil, Posaconazole Accord
- Italy · Posaconazole Eg Stada, Posaconazole Mylan
- Liechtenstein · Noxafil, Posaconazole Accord
- Lithuania · Posaconazole Stada
- Latvia · Posaconazole Stada
- Malta · Posaconazole, Posaconazole Anfarm
- Netherlands · Posaconazol 100 Mg, Posaconazol Abdi
- Norway · Noxafil, Posaconazole Accord
- Poland · Posaconazole Accord, Posaconazole Aurovitas
- Portugal · Posaconazol Almovar, Posaconazol Anfarm
- Romania · Posaconazol, Posaconazol Accord
- Sweden · Posaconazole, Posaconazole Amarox
- Slovenia · Posaconazol Msn, Posakonazol Stada
- Slovakia · Posaconazol Msn, Posaconazole Msn
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c3f5bee7-978d-43f4-8a4a-d76ad1dc0f8f GET /v1/drugs/c3f5bee7-978d-43f4-8a4a-d76ad1dc0f8f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "300",
"substance": "POSACONAZOLE",
"productndc": "0085-2224",
"dosage_form": "POWDER, FOR SUSPENSION",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA214770",
"marketing_category": "NDA"
}See everything about posaconazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.